An amino acid mutation in a potassium channel that prevents inhibition by protein kinase C

A E Busch1, M D Varnum, R A North

  • 1Vollum Institute, Oregon Health Sciences University, Portland 97201.

Science (New York, N.Y.)
|March 27, 1992
PubMed

Insights

Protein kinase C activators inhibit a rat kidney potassium channel current. This inhibition occurs via direct phosphorylation of the channel protein at Ser103, as shown by experiments with mutated channels.

Area of Science:

  • Molecular Biology
  • Neuroscience
  • Biochemistry

Background:

  • Voltage-dependent potassium channels are crucial for neuronal excitability.
  • Protein kinase C (PKC) is involved in regulating ion channel function.
  • Understanding the specific mechanisms of potassium channel modulation is vital for neuroscience research.

Purpose of the Study:

  • To investigate the effect of protein kinase C activators on a cloned rat kidney potassium channel.
  • To determine the specific site and mechanism of potassium channel inhibition by PKC.

Main Methods:

  • Expression of a rat kidney potassium channel protein in Xenopus oocytes.
  • Application of PKC activators (1-oleoyl-2-acetyl-rac-glycerol and phorbol 12,13-didecanoate) and a kinase inhibitor (staurosporine).
  • Site-directed mutagenesis of the channel protein (Ser103 to Ala) to assess the role of specific phosphorylation sites.

Main Results:

  • PKC activators significantly inhibited the potassium channel current.
  • Staurosporine blocked the inhibitory effect of PKC activators, suggesting a kinase-dependent mechanism.
  • Mutation of Ser103 to Alanine abolished the inhibition, while other channel properties remained unaffected.

Conclusions:

  • The inhibition of the rat kidney potassium channel current by PKC activators is mediated by direct phosphorylation of the channel subunit protein.
  • Serine 103 is identified as the critical site for this phosphorylation-dependent regulation.

Related Concept Videos

Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Protein Denaturation01:28

Protein Denaturation

The function of proteins depends on their native three-dimensional structure, which is dictated by the amino acid sequence of the specific protein. Folding of the polypeptide chain takes place under specific conditions that energetically favor the folded conformation. In contrast, protein denaturation occurs spontaneously under unfavorable conditions that disrupt the integrity of the folded conformation. Thus, the chemical and physical environment of a protein, such as significant changes in pH...
Amino Acid Catabolism01:18

Amino Acid Catabolism

Microorganisms rely on proteins as an essential carbon and energy source, particularly in environments with limited polysaccharides or lipids. However, proteins are too large to cross the plasma membrane unaided, necessitating enzymatic degradation. Microbes secrete extracellular proteases and peptidases that hydrolyze proteins into peptides, which can then be transported across the membrane. Once inside the cell, intracellular proteases degrade these peptides into free amino acids, which...
Bacterial Protein Maturation01:26

Bacterial Protein Maturation

Bacterial protein maturation is a tightly regulated process that ensures newly synthesized polypeptides achieve correct functional conformations. This maturation involves a series of modifications, folding events, and quality control steps, often assisted by specialized chaperone proteins.N-Terminal ModificationsThe maturation of bacterial polypeptides begins cotranslationally as the polypeptide exits the ribosome. The first amino acid, N-formylmethionine (fMet), is typically modified at the...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...